A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation.
about
Ubiquitin-Mediated Degradation of Aurora KinasesAn Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCsAurora kinase A in gastrointestinal cancers: time to targetFunctional Significance of Aurora Kinases-p53 Protein Family Interactions in CancerReprogramming with Small Molecules instead of Exogenous Transcription FactorsHuman pluripotent stem cells on artificial microenvironments: a high content perspectiveDistinct Signaling Requirements for the Establishment of ESC Pluripotency in Late-Stage EpiSCsHigh content screening for modulators of cardiac differentiation in human pluripotent stem cellsThe cytoskeletal protein RHAMM and ERK1/2 activity maintain the pluripotency of murine embryonic stem cells.Constraining the Pluripotent Fate of Human Embryonic Stem Cells for Tissue Engineering and Cell Therapy - The Turning Point of Cell-Based Regenerative Medicine.Kinome-wide functional analysis highlights the role of cytoskeletal remodeling in somatic cell reprogramming.Roles of small molecules in somatic cell reprogrammingThe use of small molecules in somatic-cell reprogramming.Genome-wide functional analysis reveals factors needed at the transition steps of induced reprogramming.MicroRNA-mediated regulation of extracellular matrix formation modulates somatic cell reprogrammingAURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.Modeling stem cell induction processes.Combining small molecules for cell reprogramming through an interatomic analysis.Small molecule screening in human induced pluripotent stem cell-derived terminal cell types.Use of human pluripotent stem cells to study and treat retinopathiesProspects for clinical use of reprogrammed cells for autologous treatment of macular degeneration.Nonviral methods for inducing pluripotency to cells.Functional impact of Aurora A-mediated phosphorylation of HP1γ at serine 83 during cell cycle progressionThree-dimensional model of mouse epidermis for experimental studies of psoriasis.Deterministic transfection drives efficient nonviral reprogramming and uncovers reprogramming barriers.Tuning cell fate: from insights to vertebrate regenerationProtein kinases and associated pathways in pluripotent state and lineage differentiation.Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.Repressors of reprogramming.Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotencyBiological Networks Governing the Acquisition, Maintenance, and Dissolution of Pluripotency: Insights from Functional Genomics Approaches.The triumph of chemically enhanced cellular reprogramming: a patent review.5-Nitro-5'hydroxy-indirubin-3'oxime is a novel inducer of somatic cell transdifferentiation.A critical role for p38MAPK signalling pathway during reprogramming of human fibroblasts to iPSCs.Mechanisms for nonmitotic activation of Aurora-A at cilia.Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.A chemical approach to myocardial protection and regeneration.Rad51 Regulates Reprogramming Efficiency through DNA Repair Pathway.Phthalazinone Pyrazole Enhances the Hepatic Functions of Human Embryonic Stem Cell-Derived Hepatocyte-Like Cells via Suppression of the Epithelial-Mesenchymal Transition.Inhibition of USP10 induces degradation of oncogenic FLT3.
P2860
Q26770280-FA28DC0C-EBD4-4E85-9327-3292C4FD1372Q26775122-0AB361B9-249A-423A-9955-FA2D858311E2Q26864277-C32CDCD7-D6F8-448F-9738-F4CA8506202FQ28071615-6289AAF3-09EE-4579-B77E-9B40BF59B28CQ28084394-BC2BFACF-9DB5-4F6B-B488-0B555E87996BQ28656439-1C14D0A8-3B44-432D-BBCB-D563237A7474Q28833820-7B21026F-F381-4E44-9ECA-575C6D287D90Q30390374-645F3042-699D-4126-9844-274042F26738Q31137596-83E03285-1F25-48E1-B35F-60174BE1BF0DQ33732794-FF8AE6DD-2203-4C6A-B23B-4E9764EC35BAQ33807533-177F9C9F-A764-4A3E-835C-E35DB48E53C1Q34037041-AFA3B13B-D8F5-4EE1-BAC9-5C99708DCA41Q34038758-F6E11CCC-F406-48C9-ACB7-CEAA96031929Q34122283-6E5B7BF1-7DE3-4490-BDF6-669B83410EADQ34547195-DB0AB4C6-4B28-4648-AC16-5F4D011CB69EQ34623325-B0A245EE-F900-44F1-8D32-12CFCDA08B16Q34716786-A28A6DE3-1650-4F2F-94F7-F6005F8C3AD9Q34993880-9A995315-32B0-43A9-AE3C-B2081E3CBCB1Q35074117-FDB9D314-D610-44DA-B766-6A7E6A504CB3Q35501343-1D54218B-E27A-4886-849D-3B3A049ACCE0Q35608700-552B61CA-D685-4FBA-A7F1-80265EFA64D3Q36956030-EAAEF7DC-80F0-4CFD-B6DC-330DD9147839Q37000839-12BC5426-AF50-4EB7-BF95-C6DA1B2F0B4CQ37475600-BD0F5A7F-6A00-4A49-8D32-73EF32BB20FBQ37509689-F478FA88-A74F-46F6-B0D3-6F854CAC7DD2Q38204883-C4E6C415-2CFE-4BD9-93D2-7B09D64183D6Q38226659-585320AD-4419-4CB7-B3AB-2A66DB9B2A0CQ38341237-40E07A4B-FE1A-423B-B90D-65731B87B93CQ38443588-32A0DCCA-763A-4E1A-A511-643E41205999Q38632891-95D0E398-7722-471F-AF67-6EB651A97134Q38638128-8CC90BD6-9516-413F-A5DF-EAF9CE411362Q38642983-93872846-F483-49F4-9427-E06413E022B9Q38943332-656DA205-FE75-4BA7-AB97-E193A588A001Q38982278-90D97631-F9CC-46BF-B4B8-0B6197E4D719Q39137312-9DBCCC2B-1E72-4F26-AB0B-8B72C6F2EEA6Q39208957-4BFBF4A8-B829-42F2-9D79-B45034CBF532Q39323701-8CAD1951-E621-45CE-B547-A4D3CBC1B0EEQ41115761-E79DC424-4078-41B3-8F7F-01B441820C3BQ47251589-CE652329-D997-4910-8700-E357E15A8565Q47716589-848DA4CB-FFD4-4B35-B2A2-ADB66C0F63FD
P2860
A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A kinase inhibitor screen iden ...... mming and iPS cell generation.
@ast
A kinase inhibitor screen iden ...... mming and iPS cell generation.
@en
type
label
A kinase inhibitor screen iden ...... mming and iPS cell generation.
@ast
A kinase inhibitor screen iden ...... mming and iPS cell generation.
@en
prefLabel
A kinase inhibitor screen iden ...... mming and iPS cell generation.
@ast
A kinase inhibitor screen iden ...... mming and iPS cell generation.
@en
P2860
P356
P1476
A kinase inhibitor screen iden ...... amming and iPS cell generation
@en
P2093
Tariq M Rana
P2860
P2888
P356
10.1038/NCOMMS2059
P407
P50
P577
2012-01-01T00:00:00Z
P5875
P6179
1005754768